Latest from BWH Newsletter
PCOS to PMOS: What the Rename Means for Your FemTech Product
On May 12, 2026, one of the most common hormonal conditions in women got a new name. Polycystic...
Investing Blind: Why Women’s Health Funding Needs a Clinical Voice
Most investor teams are thorough with the numbers. They dig into the financial model, question the growth assumptions,...
Clinical Governance in FemTech: Strategic Management & Clinical Leadership
What does clinical leadership look like when you cannot afford a full-time CMO? We have arrived at the...
Clinical Governance in FemTech: Training and Development
If clinical governance is the backbone of a credible FemTech company, then training and development is its nervous...
Clinical Governance in FemTech: Clinical Audit
How do you know your product is actually working? You've built a period tracking app, and thousands of...
Clinical Governance in FemTech: Clinical Effectiveness
This is the fourth issue in our series on Clinical Governance in FemTech. So far, we have covered...
